BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 101727)

  • 21. Preparative HPLC purification of prostaglandin endoperoxides and isolation of novel cyclooxygenase-derived arachidonic acid metabolites.
    Hecker M; Hatzelmann A; Ullrich V
    Biochem Pharmacol; 1987 Mar; 36(6):851-5. PubMed ID: 3105538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatty acids as sources of potential "magic bullets" for the modification of platelet and vascular function.
    Needleman P; Wyche A; LeDuc L; Sankarappe SK; Jakschik BA; Sprecher H
    Prog Lipid Res; 1981; 20():415-22. PubMed ID: 6804971
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of prostaglandin biosynthesis by eicosapentaenoic acid.
    Culp BR; Titus BG; Lands WE
    Prostaglandins Med; 1979 Nov; 3(5):269-78. PubMed ID: 121610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation of PG effects on the intraocular muscles of the cat by inhibition of PG synthesis.
    Wilhelm PB; Alphen GW
    Doc Ophthalmol; 1977 Feb; 42(2):417-28. PubMed ID: 405188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of itch and flare responses in human skin by prostaglandins E2 and H2 and a prostaglandin endoperoxide analog.
    Hägermark O; Strandberg K; Hamberg M
    J Invest Dermatol; 1977 Dec; 69(6):527-30. PubMed ID: 925375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cat iris sphincter smooth-muscle contraction: comparison of FP-class prostaglandin analog agonist activities.
    Sharif NA; Kaddour-Djebbar I; Abdel-Latif AA
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):152-63. PubMed ID: 18355130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosine kinase inhibitors suppress prostaglandin F2alpha-induced phosphoinositide hydrolysis, Ca2+ elevation and contraction in iris sphincter smooth muscle.
    Yousufzai SY; Abdel-Latif AA
    Eur J Pharmacol; 1998 Nov; 360(2-3):185-93. PubMed ID: 9851585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissociation of vascular resistance with endocrine pancreas secretion: the effects of epoxymethano analogs of PGH2.
    Akpan JO; Hurley MC; Pek S; Lands WE
    Prostaglandins Med; 1981 Dec; 7(6):473-81. PubMed ID: 7034020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect on deep body temperature of the intraventricular injection of two prostaglandin endoperoxide analogues [proceedings].
    Cremades-Campos A; Milton AS
    J Physiol; 1978 Sep; 282():38P. PubMed ID: 722540
    [No Abstract]   [Full Text] [Related]  

  • 30. Reactivity of isolated rat and canine pulmonary blood vessels to synthetic prostaglandin endoperoxide (PGH2) analogs.
    Chand N; Altura BM
    Prostaglandins Med; 1980 Dec; 5(6):469-75. PubMed ID: 7465693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances.
    Whitaker MO; Wyche A; Fitzpatrick F; Sprecher H; Needleman P
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5919-23. PubMed ID: 230492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchial and cardiovascular actions of prostaglandin endoperoxides and an endoperoxide analogue.
    Hedqvist P; Strandberg K; Hamberg M
    Acta Physiol Scand; 1978 Jul; 103(3):299-307. PubMed ID: 726925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of prostaglandin H2 on perinatal pulmonary circulation.
    Tod ML; Cassin S; McNamara DB; Kadowitz PJ
    Pediatr Res; 1986 Jun; 20(6):565-9. PubMed ID: 3714368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel arachidonic acid metabolites formed by prostaglandin H synthase.
    Hecker M; Ullrich V; Fischer C; Meese CO
    Eur J Biochem; 1987 Nov; 169(1):113-23. PubMed ID: 3119336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential actions of the prostaglandins on the pulmonary vascular bed.
    Kadowitz PJ; Spannhake EW; Levin JL; Hyman AL
    Adv Prostaglandin Thromboxane Res; 1980; 7():731-43. PubMed ID: 6989201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
    Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565
    [No Abstract]   [Full Text] [Related]  

  • 37. Products of cyclooxygenase mediate the responses of the guinea pig trachea to hydrogen peroxide.
    Gao Y; Vanhoutte PM
    J Appl Physiol (1985); 1993 May; 74(5):2105-11. PubMed ID: 8335536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. U-46619, a selective thromboxane A2-like agonist? [proceedings].
    Coleman RA; Humphrey PP; Kennedy I; Levy GP; Lumley P
    Br J Pharmacol; 1980 Jan; 68(1):127P-128P. PubMed ID: 7357146
    [No Abstract]   [Full Text] [Related]  

  • 39. Prostaglandins mediate the stimulatory effects of endothelin-1 on cAMP accumulation and inositol-1,4,5-trisphosphate production and contraction in cat iris sphincter.
    Yousufzai SY; Ye Z; Abdel-Latif AA
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1280-7. PubMed ID: 8531093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactions of prostaglandin endoperoxides with prostaglandin I synthetase solubilized from rabbit aorta microsomes.
    Watanabe K; Yamamoto S; Hayaishi O
    Biochem Biophys Res Commun; 1979 Mar; 87(1):192-9. PubMed ID: 110324
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.